Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 4-Hydroxymethylpyrazole | 25222-43-9 | 99.7% | 98.11 | 5 G
SDP

Supplier:  Medchemexpress LLC HY339145G

Encompass_Preferred

4-Hydroxymethylpyrazole is the primary metabolite of Fomepizole, produced through hepatic oxidative metabolism. It has a plasma concentration positively correlated with the administered dosage of Fomepizole and a relatively short half-life. It inhibits alcohol dehydrogenase (ADH) in humans and monkeys, but its inhibition constant is significantly higher than Fomepizole's, rendering its in vivo impact negligible.

  • Primary metabolite of Fomepizole
  • Produced through hepatic oxidative metabolism
  • Plasma concentration positively correlated with administered dosage
  • Relatively short half-life
  • Inhibits alcohol dehydrogenase (ADH) in humans and monkeys
  • In vivo impact negligible

Catalog No. 50-004-04450


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.